Back to Journals » Breast Cancer: Targets and Therapy » Volume 10

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Total article views   Abstract views HTML views PDF downloads Totals
6,653 Dovepress* 5,328 817+ 1,003 6,145
PubMed Central* 0 508 120 508
Totals 5,328 1,325 1,123 6,653
*Since 22 March 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
38 1 0 0 6 31

View citations on PubMed Central and Google Scholar